Federated Hermes
ATRA icon

Federated Hermes’s Atara Biotherapeutics ATRA Stock Holding History

Federated Hermes’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-130
Closed -$2.35K – 2066
2025
Q4 		$2.35K Buy
+130
New +$1.94K ﹤0.01% 1957
2024
Q3 		– Sell
-57
Closed -$485 – 2062
2024
Q2 		$485 Buy
+57
New +$857 ﹤0.01% 1974
2024
Q1 		– Sell
-19
Closed -$243 – 2033
2023
Q4 		$243 Buy
+19
New +$443 ﹤0.01% 2026
2023
Q1 		– Sell
-7
Closed -$558 – 2121
2022
Q4 		$558 Buy
+7
New +$729 ﹤0.01% 2082
2021
Q2 		– Sell
-2,179
Closed -$782K – 2203
2021
Q1 		$782K Buy
+2,179
New +$963K ﹤0.01% 1461
2020
Q3 		– Sell
-5,330
Closed -$1.94M – 2248
2020
Q2 		$1.94M Sell
5,330
-110,252
-95% -$27.9M ﹤0.01% 1005
2020
Q1 		$24.6M Buy
115,582
+24,203
+26% +$7.68M 0.07% 298
2019
Q4 		$37.6M Buy
91,379
+2,352
+3% +$811K 0.08% 265
2019
Q3 		$31.4M Buy
89,027
+47,887
+116% +$17.9M 0.08% 263
2019
Q2 		$20.7M Buy
41,140
+5,008
+14% +$3.53M 0.05% 342
2019
Q1 		$35.9M Buy
36,132
+11,648
+48% +$10.8M 0.09% 245
2018
Q4 		$21.3M Buy
24,484
+5,468
+29% +$5.08M 0.06% 306
2018
Q3 		$19.7M Hold
19,016
– – 0.05% 357
2018
Q2 		$17.5M Sell
19,016
-46
-0.2% -$49.4K 0.05% 291
2018
Q1 		$18.6M Buy
+19,062
New +$17.4M 0.05% 264

Other funds holding ATRA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Federated Hermes's ATRA Position: Q1 2026 in Review

Federated Hermes sold out of Atara Biotherapeutics (ATRA) in Q1 2026, closing a stake of 130 shares — an estimated $2.35K sold.

Federated Hermes first reported a position in ATRA in Q1 2018 and held it in 15 quarters. The position peaked at $37.6M in Q4 2019. 33 funds tracked by Wall St. Rank hold ATRA as of Q1 2026.

  • Federated Hermes reported no remaining Atara Biotherapeutics position as of Q1 2026 after selling out during the quarter.
  • Federated Hermes sold 130 Atara Biotherapeutics shares in Q1 2026, an estimated $2.35K.
  • Federated Hermes first reported a position in Atara Biotherapeutics in Q1 2018 and held it in 15 quarters.
  • Federated Hermes's Atara Biotherapeutics position peaked at $37.6M in Q4 2019.
  • 33 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.